文献速递炎症性肠病

炎症性肠病患者使用抗抑郁药相关的结局

Outcomes Associated With Anti-Depressant Use in Patients With Inflammatory Bowel Disease.
PubMed 文献 · Aliment Pharmacol Ther · 2025-06-07

这项基于电子健康记录的回顾性队列纳入4052例炎症性肠病(IBD)合并抑郁患者,比较接受与未接受抗抑郁药治疗者的IBD相关结局。治疗组IBD相关急诊就诊的aOR为0.63(95%CI 0.44-0.90),但住院(aOR 1.40,95%CI 1.20-1.62)、使用皮质类固醇(aOR 1.34,95%CI 1.16-1.55)和IBD手术(aOR 1.42,95%CI 1.17-1.71)的比值更高。作者认为抗抑郁药使用与急诊利用减少相关,住院、激素和手术增加可能反映抑郁相关的更侵袭性病程。

要点

  • IBD合并抑郁患者接受抗抑郁药治疗与IBD相关急诊就诊减少相关(aOR 0.63,95%CI 0.44-0.90)。
  • 治疗组住院(aOR 1.40)、皮质类固醇使用(aOR 1.34)和IBD手术(aOR 1.42)的比值高于未治疗组。
  • 作者认为治疗抑郁可能通过减少急诊就诊降低医疗费用。

核心结论

  • 抗抑郁药使用与IBD患者急诊利用减少相关;住院、皮质类固醇治疗和手术增加可能反映抑郁相关的更侵袭性病程。
  • 作者认为治疗IBD患者的抑郁可能通过减少急诊就诊降低医疗费用。

研究设计与样本

  • 基于电子健康记录的回顾性研究队列。
  • 以≥2个诊断代码识别IBD患者,以≥1个诊断代码识别抑郁患者。
  • 暴露为治疗IBD的药物治疗;评估抑郁代码索引日期或开始抑郁药物治疗后的IBD相关住院、手术和急诊就诊。
  • 构建多变量逻辑回归模型确定结局的比值比。
  • 共识别4052例IBD合并抑郁患者,中位年龄49岁。

主要发现

  • 队列中39%未接受抑郁药物治疗,61%接受不常用于治疗疼痛的抗抑郁药治疗。
  • 接受抑郁治疗的IBD患者较未接受抑郁治疗的IBD合并抑郁患者更少发生IBD相关急诊就诊(aOR 0.63,95%CI 0.44-0.90)。
  • 接受抑郁治疗的患者更可能住院(aOR 1.40,95%CI 1.20-1.62)。
  • 接受抑郁治疗的患者更可能接受皮质类固醇治疗(aOR 1.34,95%CI 1.16-1.55)。
  • 接受抑郁治疗的患者更可能因IBD接受手术(aOR 1.42,95%CI 1.17-1.71)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although depression is prevalent among people with inflammatory bowel diseases (IBD), the impact of treating depression is unknown. METHODS: We conducted a retrospective study in an electronic-health record-based cohort. We identified patients with IBD using ≥ 2 diagnosis codes, and patients with depression using ≥ 1 diagnosis code. The exposure was a medication for the treatment of IBD. We assessed IBD-related hospitalizations, surgery, and emergency room (ER) visits after the index date of depression code or initiation of depression medication. We constructed multivariable logistic regression models to determine the odds of the outcome. RESULTS: We identified 4052 patients with IBD and depression with a median age of 49 years. In this cohort, 39% did not receive medication for depression while 61% were treated with an antidepressant not commonly prescribed for pain. Patients with IBD treated for depression were less likely to have an IBD-related ER visit than patients with IBD and depression not treated for depression (aOR: 0.63, 95% CI: 0.44-0.90). However, patients who were treated for depression were also more likely to be hospitalised (aOR: 1.40, 95% CI: 1.20-1.62), be treated with a corticosteroid (aOR: 1.34, 95% CI: 1.16-1.55) and have surgery for IBD (aOR: 1.42, 95% CI: 1.17-1.71). CONCLUSIONS: Antidepressant use is associated with reduced ER utilisation in patients with IBD. There were also increased hospitalisations, corticosteroid treatment, and surgery, which may reflect a more aggressive disease course associated with depression. Treating depression in patients with IBD may reduce healthcare costs by decreasing ER visits.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Kochar B, Chaaban L, Kobeissi L, et al. Outcomes Associated With Anti-Depressant Use in Patients With Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2025. PMID: 40481682. doi:10.1111/apt.70229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。